期刊文献+

血清CA-125水平和非致命性心肌梗塞关系的初步探讨

Relationship between serum levels of carbohydrate antigen 125 levels and non fatal myocardial infarction in senile patients
原文传递
导出
摘要 目的就血清中CA-125的水平和人群非致命性心肌梗塞(MI)发生风险的关系作初步探讨。方法收集210例十堰市东风汽车公司离退休职工中患有非致命性MI者为病例组;另从同样的人群中不患非致命性MI及相关疾病的退休职工中随机抽取1 050例作为对照组。分别抽血检测其血清CA-125水平,同时收集体检资料及治疗情况。定量资料分析采用t检验,组间率、分类资料的分析比较采用χ2检验,血清CA-125及其他危险因素与MI的关系采用多元Logistic回归分析方法进行分析。结果病例组血清CA-125水平明显高于对照组(P<0.01)。并且随着血清CA-125水平的增高,患非致命性心肌梗塞的风险也随之升高,呈线性关系。高年龄组(≥65岁)、女性、BMI正常者、有高血压和糖尿病家族史的人群中,CA125水平高者其患非致死性MI的风险更高。结论中老年人群的血清CA-125水平越高,其患非致命性MI的风险也可能越高。CA-125可能是一个与非致命性MI相关的新的生物学标志物,但其具体机制有待于进一步的研究阐明。 Objective To investigate the relationship between the serum level of carbohydrate antigen 125 (CA-125) and non-fatal myocardial infarction (MI) risk in senile patients. Methods The 210 diagnosed non-fatal MI patients and 1050 retirees without MI and MI-related diseases were selected as controls. Serum levels of CA-125 were measured, baseline information and medication history were collected. Continuous variables were analyzed by 2-tailed t tests, Categorical data were evaluated by Chi-square test. Logistic regression was used to analysze the association between serum CA-125 and the risk of non-fatal MI. Results Serum levels of CA- 125 were significantly higher in case group than controls (P 〈 0.01 ). The MI risk increased with the level of CA-125 in a dose-response manner. Furthermore, CA-125 level-associated MI risks were higher in subjects aged over 65 years, females, normal BMI and subjects with a family history of diabetes and hypertension. Conclusions Elevated serum level of CA-125 might be associated with increased risk of non-fatal myocardial infarction in senile population. Serum CA-125 might be a new biomarker for non-fatal MI. The detailed mechanisms requires further investigations.
出处 《中国热带医学》 CAS 2014年第6期641-644,共4页 China Tropical Medicine
基金 国家自然科学基金项目(No.81172751)
关键词 心肌梗塞 癌抗原-125 关联研究 退休人群 Myocardial infarction CA- 125 Association study Retired population
  • 相关文献

参考文献14

  • 1Roger VL,Go AS ,lloyd-Jones DM,et al. Heart disease and stroke sta- tistics-2012 update:a report from the American Heart Association. Circulatlon [J]. Circulation, 2012,125(1 ): e2-e220.
  • 2Kenemans P, Yedema CA, Bon GG, et al. CA 125 in gynecological pa- thology-a review [J]. Eur J Obstet Gynecol Reprod Biol, 1993, 49 (1-2): 115-124.
  • 3De Gennaro L, Brunetti ND, Bungaro R, et al. Carbohydrate anti- gen-125: additional accuracy in identifying patients at risk of acute heart failure in acute coronary syndrome [J]. Coron Artery Dis, 2009, 20(4): 274-280.
  • 4Rostoff P, Mroczek-Czemeeka D, Piwowarska W. Elevated CA-125 level in acute heart failure due to Toxoplasma gondii perimyocarditis [J]. Int J Cardiol, 2008,130 (3): e 114-116.
  • 5ADe C, ennaro L, Brunetti ND, Montrone D, et al. Inflammatory activation and carbohydrate antigen-125 levels in subjects with atrial fibrillation [J]. Eur J Clin Invest, 2012,42(4): 371-375.
  • 6Wang F, Zhu J, Yao P, et al. Cohort profile: The Dongfeng-Tongji co- hort study of retired workers [J]. International Journal of Epidemiology, 2013,42(3): 731-740.
  • 7Fihn SD, Gardin JM, Abrams J,et al. 2012 ACCF/AHA/ACP/AATS/PC- NA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart AssociationTask Force on Practice Guidelines, and the American College of Physicians, Ameri- can Association for Thoracic Surgery, Preventive Cardiovascular Nurs- es Association, Society for Cardiovascular Angiography andinterven- tions, and Society of Thoracic Surgeons [J]. J Am CoU Cardiol, 2012,60 (24):e44--e 164.
  • 8Bast RC Jr, K.lug TL, St John E, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer [J]. N Engl J Med, 1983,309(15): 883-887.
  • 9章华础,萧祥熊.进一步探讨糖类抗原CA-125检测的临床意义[J].放射免疫学杂志,2003,16(1):1-2. 被引量:18
  • 10胡光林(译).肿瘤标记[M].北京:中国医学科技出版社,1991.14-16.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部